Skip to main content

Company

ImmuPharma PLC

LON:IMM

ImmuPharma PLC is a biopharmaceutical company that specializes in the usage and development of biopolymers, specifically peptides. The company is dedicated to developing an innovative portfolio of peptide-based therapeutic drugs with a focus on autoimmunity/inflammation and anti-infectives.

306 stories · page 3 of 16

Pharma & Biotech

ImmuPharma positive about the 'short, medium and long-term', says CEO

By Proactive 06/03/2024

Pharma & Biotech

ImmuPharma says phase III CRO has been chosen

By Proactive 19/12/2023

Pharma & Biotech

ImmuPharma hails Incanthera commercial news

By Proactive 18/12/2023

Pharma & Biotech

ImmuPharma secures further funds via retail access platform

By Proactive 07/09/2023

Pharma & Biotech

ImmuPharma carries out fundraise ahead of key development period

By Proactive 31/08/2023

Pharma & Biotech

Immupharma adds late-stage clinical pharma expert to board

By Proactive 11/08/2023

Pharma & Biotech

ImmuPharma edges closer to major breakthrough for lupus drug

By Proactive 29/06/2023

Pharma & Biotech

ImmuPharma presses on with next phase of Lupuzor clinical trials

By Proactive 19/06/2023

Pharma & Biotech

ImmuPharma shares jump 6.5% after FDA update

By Proactive 18/05/2023

Pharma & Biotech

ImmuPharma says CIDP trial will begin in the second half after meeting with US regulator

By Proactive 18/05/2023

Pharma & Biotech

ImmuPharma eyes clinical trial progress

By Proactive 11/05/2023

Pharma & Biotech

ImmuPharma partner gets FDA meeting date

By Proactive 19/04/2023

Moderna, Legend Biotech advanced to the major league from the minors. But how do you spot a rookie company ready to move to the ‘show’?

By Proactive 14/04/2023

Pharma & Biotech

ImmuPharma rises 4% after it reveals headway with lead asset

By Proactive 12/04/2023

Pharma & Biotech

ImmuPharma makes progress developing second indication for lead asset

By Proactive 12/04/2023

Pharma & Biotech

ImmuPharma: US partner submits Lupuzor phase II/III trial protocol

By Proactive 27/03/2023

Pharma & Biotech

ImmuPharma collaborates on potential 'radioactive bullet' to kill cancer

By Proactive 06/03/2023

Pharma & Biotech

ImmuPharma partner agrees phase II/III clinical trial process

By Proactive 06/02/2023

Pharma & Biotech

ImmuPharma says it has ‘clear objective’ to advance lupus treatment to next clinical trial in 2023

By Proactive 22/12/2022

Pharma & Biotech

ImmuPharma’s US partner confirms support for lupus treatment, wants to expand collaboration

"We have had extremely positive discussions with Avion over the last month"

By Proactive 11/11/2022